Posted by Michael Wonder on 31 Jan 2021
Schedule of Pharmaceutical Benefits - 1 February 2021
1 February 2021 - The February 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The February issue of the Schedule includes a few new/revised listings:
- Carfilzomib (Kyprolis) - restriction change
- Lisdexamphetamine mesylate (Vyvanse) - restriction change
- Selexipag (Uptravi) - new medicine
- Bricanyl (terbutaline sulphate) - new formulation
Read Summary of Changes
Posted by:
Michael Wonder